CYCLIN K down-regulation induces androgen receptor gene intronic polyadenylation, variant expression and PARP inhibitor vulnerability in castration-resistant prostate cancer
出版年份 2022 全文链接
标题
CYCLIN K down-regulation induces androgen receptor gene intronic polyadenylation, variant expression and PARP inhibitor vulnerability in castration-resistant prostate cancer
作者
关键词
-
出版物
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume 119, Issue 39, Pages -
出版商
Proceedings of the National Academy of Sciences
发表日期
2022-09-22
DOI
10.1073/pnas.2205509119
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Pain and health-related quality of life with olaparib versus physician's choice of next-generation hormonal drug in patients with metastatic castration-resistant prostate cancer with homologous recombination repair gene alterations (PROfound): an open-label, randomised, phase 3 trial
- (2022) Antoine Thiery-Vuillemin et al. LANCET ONCOLOGY
- Rational Second-Generation Antiandrogen Use in Prostate Cancer
- (2022) Jacob J Orme et al. ONCOLOGIST
- Shift in MSL1 alternative polyadenylation in response to DNA damage protects cancer cells from chemotherapeutic agent-induced apoptosis
- (2021) Alexander K. Kunisky et al. Cell Reports
- Transcription-Associated Cyclin-Dependent Kinases as Targets and Biomarkers for Cancer Therapy
- (2020) Jonathan Chou et al. Cancer Discovery
- APAlyzer: a bioinformatics package for analysis of alternative polyadenylation isoforms
- (2020) Ruijia Wang et al. BIOINFORMATICS
- CDK12 inhibition reduces abnormalities in cells from patients with myotonic dystrophy and in a mouse model
- (2020) Ami Ketley et al. Science Translational Medicine
- The CDK inhibitor CR8 acts as a molecular glue degrader that depletes cyclin K
- (2020) Mikołaj Słabicki et al. NATURE
- DNA Damage Promotes TMPRSS2-ERG Oncoprotein Destruction and Prostate Cancer Suppression via Signaling Converged by GSK3β and WEE1
- (2020) Zhe Hong et al. MOLECULAR CELL
- Survival with Olaparib in Metastatic Castration-Resistant Prostate Cancer
- (2020) Maha Hussain et al. NEW ENGLAND JOURNAL OF MEDICINE
- CDK12 phosphorylates 4E-BP1 to enable mTORC1-dependent translation and mitotic genome stability
- (2019) Seung H. Choi et al. GENES & DEVELOPMENT
- A PolH transcript with a short 3'UTR enhances PolH expression and mediates cisplatin resistance
- (2019) Jin Zhang et al. CANCER RESEARCH
- CDK12 loss in cancer cells affects DNA damage response genes through premature cleavage and polyadenylation
- (2019) Malgorzata Krajewska et al. Nature Communications
- CDK12 inhibition mediates DNA damage and is synergistic with sorafenib treatment in hepatocellular carcinoma
- (2019) Cun Wang et al. GUT
- Ex vivo screen identifies CDK12 as a metastatic vulnerability in osteosarcoma
- (2019) Ian Bayles et al. JOURNAL OF CLINICAL INVESTIGATION
- Therapeutic Targeting of CDK12/CDK13 in Triple-Negative Breast Cancer
- (2019) Victor Quereda et al. CANCER CELL
- Clinical Outcomes in Cyclin-dependent Kinase 12 Mutant Advanced Prostate Cancer
- (2019) Melissa A. Reimers et al. EUROPEAN UROLOGY
- Inactivation of CDK12 Delineates a Distinct Immunogenic Class of Advanced Prostate Cancer
- (2018) Yi-Mi Wu et al. CELL
- Genomic Hallmarks and Structural Variation in Metastatic Prostate Cancer
- (2018) David A. Quigley et al. CELL
- Structural Alterations Driving Castration-Resistant Prostate Cancer Revealed by Linked-Read Genome Sequencing
- (2018) Srinivas R. Viswanathan et al. CELL
- Olaparib combined with abiraterone in patients with metastatic castration-resistant prostate cancer: a randomised, double-blind, placebo-controlled, phase 2 trial
- (2018) Noel Clarke et al. LANCET ONCOLOGY
- Androgen receptor splice variants bind to constitutively open chromatin and promote abiraterone-resistant growth of prostate cancer
- (2018) Yundong He et al. NUCLEIC ACIDS RESEARCH
- Widespread intronic polyadenylation diversifies immune cell transcriptomes
- (2018) Irtisha Singh et al. Nature Communications
- Androgen receptor splice variant-7 expression emerges with castration resistance in prostate cancer
- (2018) Adam Sharp et al. JOURNAL OF CLINICAL INVESTIGATION
- CDK12 regulates DNA repair genes by suppressing intronic polyadenylation
- (2018) Sara J. Dubbury et al. NATURE
- Intrinsic BET inhibitor resistance in SPOP-mutated prostate cancer is mediated by BET protein stabilization and AKT–mTORC1 activation
- (2017) Pingzhao Zhang et al. NATURE MEDICINE
- Androgen receptor inhibitor–induced “BRCAness” and PARP inhibition are synthetically lethal for castration-resistant prostate cancer
- (2017) Likun Li et al. Science Signaling
- Synthetic lethality between androgen receptor signalling and the PARP pathway in prostate cancer
- (2017) Mohammad Asim et al. Nature Communications
- Androgen receptor inhibitor–induced “BRCAness” and PARP inhibition are synthetically lethal for castration-resistant prostate cancer
- (2017) Likun Li et al. Science Signaling
- Transcriptional termination in mammals: Stopping the RNA polymerase II juggernaut
- (2016) N. J. Proudfoot SCIENCE
- Activation of P-TEFb by Androgen Receptor-Regulated Enhancer RNAs in Castration-Resistant Prostate Cancer
- (2016) Yu Zhao et al. Cell Reports
- Association of AR-V7 on Circulating Tumor Cells as a Treatment-Specific Biomarker With Outcomes and Survival in Castration-Resistant Prostate Cancer
- (2016) Howard I. Scher et al. JAMA Oncology
- The end of the message: multiple protein–RNA interactions define the mRNA polyadenylation site
- (2015) Yongsheng Shi et al. GENES & DEVELOPMENT
- 3' end formation of pre-mRNA and phosphorylation of Ser2 on the RNA polymerase II CTD are reciprocally coupled in human cells
- (2014) L. Davidson et al. GENES & DEVELOPMENT
- CFIm25 links alternative polyadenylation to glioblastoma tumour suppression
- (2014) Chioniso P. Masamha et al. NATURE
- AR-V7 and Resistance to Enzalutamide and Abiraterone in Prostate Cancer
- (2014) Emmanuel S. Antonarakis et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ubiquitously transcribed genes use alternative polyadenylation to achieve tissue-specific expression
- (2013) S. Lianoglou et al. GENES & DEVELOPMENT
- Androgen Receptor Signaling Regulates DNA Repair in Prostate Cancers
- (2013) W. R. Polkinghorn et al. Cancer Discovery
- The Conserved Intronic Cleavage and Polyadenylation Site of CstF-77 Gene Imparts Control of 3′ End Processing Activity through Feedback Autoregulation and by U1 snRNP
- (2013) Wenting Luo et al. PLoS Genetics
- A quantitative atlas of polyadenylation in five mammals
- (2012) Adnan Derti et al. GENOME RESEARCH
- Analysis of alternative cleavage and polyadenylation by 3′ region extraction and deep sequencing
- (2012) Mainul Hoque et al. NATURE METHODS
- Androgen Deprivation Causes Epithelial-Mesenchymal Transition in the Prostate: Implications for Androgen-Deprivation Therapy
- (2011) Y. Sun et al. CANCER RESEARCH
- Alternatively spliced androgen receptor variants
- (2011) Scott M Dehm et al. ENDOCRINE-RELATED CANCER
- The Cyclin K/Cdk12 complex maintains genomic stability via regulation of expression of DNA damage response genes
- (2011) D. Blazek et al. GENES & DEVELOPMENT
- Differential genome-wide profiling of tandem 3' UTRs among human breast cancer and normal cells by high-throughput sequencing
- (2011) Y. Fu et al. GENOME RESEARCH
- Complex and dynamic landscape of RNA polyadenylation revealed by PAS-Seq
- (2011) P. J. Shepard et al. RNA
- CDK12 is a transcription elongation-associated CTD kinase, the metazoan ortholog of yeast Ctk1
- (2010) B. Bartkowiak et al. GENES & DEVELOPMENT
- Constitutively active androgen receptor splice variants expressed in castration-resistant prostate cancer require full-length androgen receptor
- (2010) P. A. Watson et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Reprogramming of 3′ Untranslated Regions of mRNAs by Alternative Polyadenylation in Generation of Pluripotent Stem Cells from Different Cell Types
- (2009) Zhe Ji et al. PLoS One
- Progressive lengthening of 3' untranslated regions of mRNAs by alternative polyadenylation during mouse embryonic development
- (2009) Z. Ji et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Development of a Second-Generation Antiandrogen for Treatment of Advanced Prostate Cancer
- (2009) C. Tran et al. SCIENCE
- Alternative isoform regulation in human tissue transcriptomes
- (2008) Eric T. Wang et al. NATURE
- Proliferating Cells Express mRNAs with Shortened 3' Untranslated Regions and Fewer MicroRNA Target Sites
- (2008) R. Sandberg et al. SCIENCE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started